Arteriovenous malformation

Arteriovenous malformation is an abnormal tangle of blood vessels connecting arteries and veins, bypassing the capillary bed. This congenital vascular anomaly most commonly occurs in the brain and spinal cord, but can also be found in the lungs and other organs. The direct high-flow connection creates a fragile nidus prone to rupture, leading to serious complications like hemorrhagic stroke.

Overview

An arteriovenous malformation is a complex vascular lesion characterized by a direct connection between the arterial and venous systems without an intervening capillary bed. This results in a high-pressure, high-flow shunt through a tangled web of vessels known as the nidus. While often present from birth due to errors during fetal development, they may remain asymptomatic for decades. The most clinically significant and well-studied type is the cerebral arteriovenous malformation, which poses a significant risk for intracranial hemorrhage. The foundational understanding and classification of these lesions were advanced by work from pioneers like Harvey Cushing and later refined through the Spetzler-Martin grading scale, developed at Barrow Neurological Institute.

Signs and symptoms

Clinical presentation is highly variable and depends on the location and size of the lesion. Many are discovered incidentally during imaging for unrelated issues. Symptomatic presentations often include severe, sudden-onset headache, which may signal a hemorrhage. Neurological symptoms can include focal or generalized seizures, progressive neurological deficits such as weakness or numbness, and in spinal lesions, myelopathy or radiculopathy. Specific syndromes may arise based on location; for example, a malformation in the visual cortex may cause visual field deficits, while one near the brainstem can affect cranial nerve function. The classic audible finding, a cranial bruit, is now rarely detected.

Causes and pathophysiology

The precise cause is not fully understood but is believed to be a sporadic error during angiogenesis in utero, where capillaries fail to form properly between the growing arterial and venous networks. This results in persistent direct connections, forming the nidus. The pathophysiology centers on the hemodynamic consequences: high arterial pressure is transmitted directly into thin-walled draining veins, making them susceptible to rupture and hemorrhage. Over time, this abnormal flow can lead to vascular remodeling, arterial steal phenomena diverting blood from normal brain tissue, and venous hypertension. While most are isolated, a genetic association exists with hereditary hemorrhagic telangiectasia, also known as Osler-Weber-Rendu disease.

Diagnosis

Diagnosis is primarily achieved through advanced neuroimaging. Non-contrast computed tomography is often the first test in an emergency setting to detect acute hemorrhage. Magnetic resonance imaging and magnetic resonance angiography provide superior anatomical detail of the nidus and its relationship to critical brain structures like the motor cortex or thalamus. The definitive diagnostic gold standard is digital subtraction angiography, performed by an interventional neuroradiologist, which dynamically visualizes the arterial feeders, nidus architecture, and venous drainage pattern. This detailed map is essential for planning treatment and utilizes grading systems like the Spetzler-Martin scale to assess surgical risk.

Treatment

Management is multidisciplinary, involving neurosurgeons, interventional neuradiologists, and radiation oncologists at specialized centers like Cleveland Clinic or Mayo Clinic. Treatment strategies aim to completely obliterate the nidus to eliminate hemorrhage risk. Options include microsurgical resection, which offers immediate cure for accessible lesions. Endovascular embolization uses agents like Onyx or N-butyl cyanoacrylate glue to block feeders, often as a preoperative adjunct. Stereotactic radiosurgery, such as with a Gamma Knife or CyberKnife, delivers focused radiation to induce gradual sclerosis over 1-3 years. The choice depends on factors like the Spetzler-Martin grade, patient age, and clinical presentation.

Prognosis

The natural history and prognosis are variable. The major lifelong risk is hemorrhage, with an estimated annual rate of 1-3% for an unruptured cerebral lesion, which may increase after an initial bleed. Outcomes following hemorrhage depend on the location and severity; they can range from full recovery to severe disability or death. Successful complete obliteration via treatment greatly reduces, but does not entirely eliminate, future bleeding risk. Long-term prognosis is influenced by the lesion's eloquence, the pattern of venous drainage, and the presence of associated aneurysms. Regular follow-up with imaging is typically required to monitor for recurrence or complications. Category:Vascular diseases Category:Neurological disorders Category:Congenital disorders